|
Title: A patient is receiving irinotecan (Camptosar), along with other antineoplastic drugs, as treatment ... Post by: bbergeron11 on Sep 14, 2022 A patient is receiving irinotecan (Camptosar), along with other antineoplastic drugs, as treatment for ovarian cancer. The nurse will monitor for which potentially life-threatening adverse effect that is associated with this drug? ▸ Severe stomatitis ▸ Bone marrow suppression ▸ Delayed-onset cholinergic diarrhea ▸ Immediate and severe nausea and vomiting Title: A patient is receiving irinotecan (Camptosar), along with other antineoplastic drugs, as treatment ... Post by: pedro0811 on Sep 14, 2022 Content hidden
|